Abeona Therapeutics reports Q2 ZEVA Skin revenue of $11.4 million
Abeona Therapeutics said Q2 2026 ZEVA Skin revenue was $11.4 million, up 31% from Q1, after treating five patients in the quarter and expanding to seven activated QTCs.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
Abeona Therapeutics said Q2 2026 ZEVA Skin revenue was $11.4 million, up 31% from Q1, after treating five patients in the quarter and expanding to seven activated QTCs.
ABEO - Abeona Therapeutics® to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026